Cited by 147Neuroinflammation and Neurodegeneration MechanismsAmyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation

Open access
Lall, Deepti, Lorenzini, Ileana, Mota, Thomas A., Bell, Shaughn, Mahan, Thomas E., Ulrich, Jason D., Davtyan, Hayk, Rexach, Jessica E. +12 more·2021·Neuron

Abstract

C9orf72 repeat expansions cause inherited amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD) and result in both loss of C9orf72 protein expression and production of potentially toxic RNA and dipeptide repeat proteins. In addition to ALS/FTD, C9orf72 repeat expansions have been reported in a broad array of neurodegenerative syndromes, including Alzheimer's disease. Here we show that C9orf72 deficiency promotes a change in the homeostatic signature in microglia and a transition to an inflammatory state characterized by an enhanced type I IFN signature. Furthermore, C9orf72-depleted microglia trigger age-dependent neuronal defects, in particular enhanced cortical synaptic pruning, leading to altered learning and memory behaviors in mice. Interestingly, C9orf72-deficient microglia promote enhanced synapse loss and neuronal deficits in a mouse model of amyloid accumulation while paradoxically improving plaque clearance. These findings suggest that altered microglial function due to decreased C9orf72 expression directly contributes to neurodegeneration in repeat expansion carriers independent of gain-of-function toxicities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2021.05.020

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Microglial impairment from decreased C9ORF72 expression directly contributes to neurodegeneration in C9-ALS.

    “Thus, the authors argued that microglial impairment from decreased C9ORF72 expression directly contributed to neurodegeneration in C9-ALS.362”
  • Loss of C9orf72 promoted microglial gene signature transition from homeostatic to an inflammatory state characterized by an enhanced type I IFN signature.

    “Results showed that loss of C9orf72 promoted microglial gene signature transition from homeostatic to an inflammatory state characterized by an enhanced type I IFN signature.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 99 · Cited by 147

Authors
Lall, D., Lorenzini, I., Mota, T. A., Bell, S., Mahan, T. E., Ulrich, J. D., Davtyan, H., Rexach, J. E., Muhammad, A. K. M. G., Shelest, O., Landeros, J., Vazquez, M., Kim, J., Ghaffari, L., O’Rourke, J. G., Geschwind, D. H., Blurton-Jones, M., Holtzman, D. M., Sattler, R., & Baloh, R. H.
Affiliations
  • Cedars-Sinai Medical Center (US)
  • Barrow Neurological Institute (US)
  • Washington University in St. Louis (US)
  • University of California, Irvine (US)
  • University of California, Los Angeles (US)
Corresponding author
  • Sattler, Rita
  • Baloh, Robert H.
Venue
Neuron
Publisher
Elsevier BV
Published
2021-07
Volume
109
Issue
14
Pages
2275-2291.e8
ISSN
0896-6273 (ISSN-L)
OpenAlex
W3171061510
Cited by
147
References
99
Citations by year
2026: 21 · 2025: 31 · 2024: 24 · 2023: 36 · 2022: 26 · 2021: 8 · 2020: 1
FWCI
9.58
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Institute on Aging (R01AG047644, P50AG016573, RF1AG055524, R01AG061895, RF1AG047644, P30AG066519, R01AG056303)
  • National Institute of Neurological Disorders and Stroke (R01NS097545, R01NS085207, K08NS105916, R25NS065723, R01NS090934, UE5NS065723, RF1NS090934)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
C9orf72, repeat expansion, microglia, synaptic pruning, synaptic loss, aging, amyloid accumulation, Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, type I interferon, neuroinflammation, learning and memory, plaque clearance, neurodegeneration
MeSH terms
C9orf72 Protein, Aging, Amyloid, Animals, Disease Models, Animal, Lysosomes, Synapses, Microglia, Mice, Knockout, DNA Repeat Expansion, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review